Text Size
33 studies found for:    "Sialadenitis"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Rituximab in IgG4-related Disease: A Phase 1-2 Trial
Conditions: Retroperitoneal Fibrosis;   Autoimmune Pancreatitis;   Sialadenitis;   Pseudotumor
Intervention: Drug: Rituximab
2 Recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age
Condition: Measles, Mumps and Rubella Diseases
Interventions: Biological: Priorix®;   Biological: Merck's M-M-R®II, Measles, Mumps, and Rubella Virus Vaccine (also known as M-M-R Vax Pro™);   Biological: Kinrix®;   Biological: Varivax®
3 Active, not recruiting Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027 AM1)
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MMRV (AMP);   Biological: MMRV (2006 process)
4 Completed A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children
Condition: The Study Focused on the Safety of Attenuated Mumps Vaccine (Human Diploid Cell) Against Mumps in Chinese Adults, Children and Infants.
Interventions: Biological: 3.50±0.25logCCID50/ml;   Biological: 4.25±0.25 logCCID50/ml;   Biological: 5.00±0.25 logCCID50/ml;   Biological: 0 logCCID50/ml;   Biological: Attenuated Mumps vaccine (Zhe Jiang Vacn Bio-pharmaceutical Co., LTD.; NO.20110528-1)
5 Completed Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Conditions: Measles;   Mumps;   Rubella;   Chickenpox
Intervention: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine)
6 Completed Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine
Conditions: Rubella;   Varicella;   Mumps;   Measles
Interventions: Biological: MMRV;   Biological: MMR (Priorix®);   Biological: Varicella (Varilrix®)
7 Terminated
Has Results 		A Study of ProQuad™ in Healthy Children in Korea (V221-023)
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (ProQuad™);   Biological: M-M-R™ II and Varivax™
8 Enrolling by invitation Measles, Mumps, and Rubella (MMR) Immunity in College Students
Conditions: Measles;   Mumps;   Rubella
Intervention: Biological: MMR vaccine
9 Completed Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Conditions: Rubella;   Mumps;   Measles;   Chickenpox
Intervention: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine)
10 Completed Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention: Biological: MeMuRu-OKA (study vaccine)
11 Terminated Immune Responses to Two Dose Varivax +/- MMR-II
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MMR-II;   Biological: Pro-Quad;   Biological: Varivax
12 Recruiting Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations
Conditions: Measles;   Mumps;   Rubella
Intervention: Biological: MMR Vaccine
13 Completed Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention: Biological: V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks
14 Completed Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM
Conditions: Rubella;   Varicella;   Mumps;   Measles
Interventions: Biological: GSK Biological's investigational MMRV vaccine 208136;   Biological: Priorix™;   Biological: Varilrix™
15 Completed Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.
Conditions: Measles;   Mumps;   Rubella
Intervention: Biological: MMR vaccine (Priorix)
16 Not yet recruiting Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines
Conditions: Mumps;   Rubella;   Measles;   Varicella
Interventions: Biological: Priorix-Tetra™;   Other: Safety data collection
17 Completed Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly
Conditions: Varicella;   Measles;   Mumps;   Rubella;   Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B;   Haemophilus Infections
Intervention: Biological: ProQuad® and Infanrix® hexa
18 Completed Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers
Conditions: Japanese Encephalitis;   Measles;   Mumps;   Rubella
Intervention: Biological: Japanese encephalitis chimeric virus: Measles, mumps, and rubella live attenuated virus
19 Completed Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
Conditions: Rubella;   Varicella;   Mumps;   Measles;   Measles-Mumps-Rubella-Varicella Vaccine
Interventions: Biological: PriorixTM;   Biological: VarilrixTM;   Biological: GSK Biologicals' vaccine 208136
20 Completed Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine
Conditions: Measles;   Mumps;   Rubella;   Hepatitis A
Interventions: Biological: Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella;   Biological: Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine
To Top

Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results
† Indicates status has not been verified in more than two years